Integrated Care for the Use of Direct-acting Antivirals in Patients With Chronic Hepatitis C and Substance Use Disorder-Reference-Cited by-同舟云学术

Integrated Care for the Use of Direct-acting Antivirals in Patients With Chronic Hepatitis C and Substance Use Disorder

Published:2018-09 Issue:5 Volume:12 Page:346-352
ISSN:1932-0620
Container-title:Journal of Addiction Medicine
language:en
Short-container-title:

Author:

Trabut Jean-Baptiste,Barrault Camille,Charlot Hélène,Carmona Damien,Bourdel Anne,Benslimane Mustapha,François Murielle,Kini-Matondo Willy,Causse Richard,Roudot-Thoraval Françoise,Hézode Christophe

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference37 articles.

1. Global estimates of prevalence of HCV infection among injecting drug users;Aceijas;Int J Drug Policy,2007

2. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents;Alavi;Liver Int,2014

3. Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials;Arias;Antivir Ther,2017

4. A method for calculating adherence to polypharmacy from dispensing data records;Arnet;Int J Clin Pharm,2014

5. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis;Aspinall;Clin Infect Dis,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders;Addiction Science & Clinical Practice;2024-06-25

2. Adherence to Hepatitis C Treatment Among Underserved Patients With Substance Use Disorder in a Pharmacist-led Treatment Model;Journal of Pharmacy Practice;2023-03-16

3. Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program;Journal of Addiction Medicine;2021-09-02

4. Efficacy and safety of ledipasvir/sofosbuvir for hepatitis C among drug users: a systematic review and meta-analysis;Virology Journal;2021-07-27

5. Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City;Harm Reduction Journal;2021-03-31